22 completed, 18 unknown, 11 recruiting, 6 not yet recruiting. 11 Not applicable, 6 Phase 2, 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 11 | Completed 5, Not yet recruiting 2, Recruiting 2, Unknown 1, Withdrawn 1 |
| Phase 2 | 6 | Completed 3, Unknown 2, Recruiting 1 |
| Phase 3 | 2 | Unknown 2 |
| Phase 4 | 1 | Unknown 1 |
Follow Biomarker: new trials by email Literature Review of Biomarker trials Research Report on Biomarker
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PROstate Cancer Risk Calculator for ACTionable Clinical Decision-making in Nigeria (a) Training and (b) Supported risk assessment - Prostate Cancer, Risk Assessment | Not applicable | Not yet recruiting | Ahmadu Bello University | 89 | 2029-03-01 | 2026-07-29 |
| Effects of Supervised Aerobic Exercise on Biomarkers in Patients With nSCLC Receiving Immunotherapy Exercise - Non-Small Cell Lung Cancer, Aerobic Exercise | Not applicable | Not yet recruiting | Izmir Bakircay University | 78 | 2027-01-04 | 2026-10-21 |
| The Application of Biomarkers in the Care of Patients With Atrial Fibrillation Atrial Fibrillation, Biomarker | Withdrawn | National Taiwan University Hospital | 2026-01-01 | 2026-05-07 | ||
| Diagnostic and Prognostic Evaluation of Vasorin During Septic Shock blood sample - Vasorin, Septic Shock | Not applicable | Recruiting | Centre Hospitalier Universitaire, Amiens | 144 | 2025-10-19 | 2026-01-07 |
| Novel Biomarkers and Postoperative Kidney Injury in Radical Nephrectomy Nephrectomy, Acute Kidney Injury | Recruiting | Peking University First Hospital | 60 | 2025-08-02 | 2025-09-08 | |
| DYNAMIC-UC: Early qFIT and Calprotectin Change Predicting Relapse in Biologic-Naive Ulcerative Colitis FC and FIT TEST at WEEK0 2 4 - Ulcerative Colitis (UC), Fecal Calprotetin | Recruiting | Qilu Hospital of Shandong University | 100 | 2025-08-01 | 2026-07-28 | |
| Study of Peripheral Blood CHI3L1 to Predict Tumor Response to Radiotherapy Tumor, Radiotherapy | Not yet recruiting | Nanfang Hospital, Southern Medical University | 338 | 2025-07-20 | 2025-07-17 | |
| ''Comparative Evaluation of Change in Bite Force and Levels of Bone Turnover Markers CTX and BALP in Hyperdivergent and Hypodivergent Cases During Retention Phases-A Prospective Clinical Trial '' Bite force and Gcf - Relapse, Bite Force | Not applicable | Recruiting | Postgraduate Institute of Dental Sciences Rohtak | 40 | 2024-12-25 | 2024-12-10 |
| Customized Circulating Tumor DNA Testing for Cervical Cancer Recurrence Surveillance and Treatment Decisions Immunotherapy, Cervical Cancer | Not yet recruiting | Peking Union Medical College Hospital | 60 | 2024-12-20 | 2024-12-19 | |
| Association of POCD With Circulating Biomarkers in Patients Undergoing TUR of Bladder Tumor Cognitive Decline, Urinary Bladder Cancer | Recruiting | Osijek University Hospital | 42 | 2024-11-28 | 2025-09-10 | |
| S100A8 in Serum and Urine as a New Biomarker in Lupus Nephritis S100A8, Serum | Completed | Theodor Bilharz Research Institute | 70 | 2024-11-01 | 2025-05-21 | |
| A Biomarker Exploration Study of Precision Treatment in Ovarian Cancer Sequencing of DNA, RNA, and Proteins - Ovarian Cancer, Biomarker | Active not recruiting | Tongji Hospital | 2000 | 2024-03-01 | 2024-07-03 | |
| Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy Immunotherapy, Hyperprogression | Recruiting | Nanfang Hospital, Southern Medical University | 374 | 2024-02-18 | 2024-03-15 | |
| Plasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis Nasopharyngeal Carcinoma, Head and Neck Cancer | Recruiting | Nanfang Hospital, Southern Medical University | 300 | 2024-02-01 | 2024-03-12 | |
| A Bidirectional Cohort Study of COMMD10 Expression in Tumor Tissues for Predicting Radiosensitivity Biomarker, Radiosensitivity | Unknown | Nanfang Hospital, Southern Medical University | 400 | 2023-12-01 | 2024-03-15 | |
| The Correlation Between Ovarian Function and Serum Biomarkers blood test - Premature Ovarian Insufficiency, Diminished Ovarian Reserve | Recruiting | Shi Yun | 35 | 2023-10-25 | 2024-12-09 | |
| Study of Biomarkers in Diabetic Chronic Wounds collect whole blood, urine and stool samples - Diabetes Mellitus, Biomarker | Unknown | Yibing Wang | 930 | 2023-07-01 | 2024-04-16 | |
| Soluble B7-H3 as a Biomarker for Osteosarcoma ELISA: enzyme-linked immunosorbent assay - Biomarker, Progression | Unknown | Peking University People's Hospital | 200 | 2023-06-05 | 2024-05-14 | |
| Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II Detection of genotype and RNA profile in platelet and white blood cell, Indicators test related to coagulation function, Indicators test related to platelet function - Novel Oral Anticoagulants, NOACs | Not yet recruiting | Peking University First Hospital | 2000 | 2023-03-01 | 2023-03-10 | |
| A Novel Biomarker for Response and Prognosis of HBV-related Hepatocellular Carcinoma Hepatocellular Carcinoma, Hepatitis b Virus | Not yet recruiting | National Taiwan University Hospital | 95 | 2023-03-01 | 2023-03-03 |
Showing 20 of 62. Sign in to see all of them.
Disease (6) · Cognitive Dysfunction (4) · Carcinoma, Non-Small-Cell Lung (3) · Neoplasms (3) · Stroke (3) · Acute Kidney Injury (2) · Arthritis, Rheumatoid (2) · Cholangiocarcinoma (2) · Disease Progression (2) · Heart Failure (2) · Inflammation (2) · Motor Activity (2) · Osteosarcoma (2) · Shock, Septic (2) · Urinary Bladder Neoplasms (2)
Pathological Conditions, Signs and Symptoms (19) · Pathologic Processes (18) · Neoplasms (16) · Neoplasms by Site (14) · Urogenital Diseases (11) · Female Urogenital Diseases (10) · Female Urogenital Diseases and Pregnancy Complications (10) · Male Urogenital Diseases (7) · Cardiovascular Diseases (6) · Digestive System Diseases (6) · Neoplasms by Histologic Type (6) · Nervous System Diseases (6) · Urogenital Neoplasms (6) · Urologic Diseases (6) · Brain Diseases (5)
Blood Specimen Collection (2) · Urination (2) · apatinib (2) · 1-palmityl-2-(4-carboxybutyl)-sn-glycero-3-phosphocholine (1) · 130-nm albumin-bound paclitaxel (1) · Autopsy (1) · Bite Force (1) · Capecitabine (1) · Carboplatin (1) · Electrocardiography, Ambulatory (1) · Exercise (1) · Fluorouracil (1) · GLPG0634 (1) · Hematologic Tests (1) · Immunohistochemistry (1)
Nanfang Hospital, Southern Medical University (4) · Peking Union Medical College Hospital (3) · Atsushi Kawakami (2) · National Taiwan University Hospital (2) · Peking University First Hospital (2) · Ahmadu Bello University (1) · Assistance Publique - Hôpitaux de Paris (1) · Azienda Ospedaliero, Universitaria Pisana (1) · Beijing Tongren Hospital (1) · Biruni University (1) · Byung-Kiu Park (1) · CENTOGENE GmbH Rostock (1) · Centre Hospitalier Universitaire, Amiens (1) · Cheng-Hsin General Hospital (1) · Chinese Alliance Against Lung Cancer (1)
China (23) · United States (4) · Egypt (3) · France (3) · Japan (3) · South Korea (3) · Germany (2) · India (2) · Italy (2) · Romania (2) · Taiwan (2) · Albania (1) · Austria (1) · Belgium (1) · Brazil (1)
Atsushi Kawakami, MD, PhD (2) · Angela Jefferson, PhD (1) · Bo Zhu (1) · Byung-Kiu Park, M.D., Ph.D. (1) · Chao Zheng, MD,PhD (1) · Chia-Hsien Cheng (1) · Daihong Liu (1) · Eisei Noiri, M.D., Ph.D. (1) · Elena I. Ivleva, MD, PhD (1) · Farkhad Manapov, PhD MD (1) · Fatma D Arslan, MD, Prof. (1) · Fei Yan, Master (1) · Grzegorz Opolski, Professor (1)
PMID 20375404, PMID 24019397, PMID 24376064, PMID 24581682, PMID 29558241, PMID 29663291, PMID 30015290, PMID 31109809, PMID 31451841, PMID 32112738, PMID 32376724, PMID 32448804, PMID 32753952, PMID 32832493, PMID 32948120, PMID 33087333, PMID 33411755, PMID 33912461, PMID 34355628, PMID 34378330, PMID 35029189, PMID 35958344, PMID 36869356, PMID 37521287, PMID 41499358, PMID 42036316
K43TW013133 (1), P20AG068082 (1), R01MH127317 (1)